{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:51:55Z","timestamp":1773701515886,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-09847-w","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:26:11Z","timestamp":1773656771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The secretory protein, CLCF1, improves cholestatic liver disease by inhibiting hepatic bile acid synthesis and promoting bile acid excretion"],"prefix":"10.1038","volume":"9","author":[{"given":"Man","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingxi","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suriguge","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinglan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongsheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0424-7348","authenticated-orcid":false,"given":"Lu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"9847_CR1","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jhep.2022.05.044","volume":"77","author":"I Labiano","year":"2022","unstructured":"Labiano, I. et al. TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation. J. Hepatol. 77, 991\u20131004 (2022).","journal-title":"J. Hepatol."},{"key":"9847_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jhep.2021.02.035","volume":"75","author":"J Li","year":"2021","unstructured":"Li, J. et al. Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism. J. Hepatol. 75, 400\u2013413 (2021).","journal-title":"J. Hepatol."},{"key":"9847_CR3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/HEP.0000000000001341","volume":"82","author":"B Mol","year":"2025","unstructured":"Mol, B. et al. Epidemiological and economical burden of cholestatic liver disease. Hepatology 82, 813\u2013833 (2025).","journal-title":"Hepatology"},{"key":"9847_CR4","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.jhep.2023.08.016","volume":"79","author":"R Chen","year":"2023","unstructured":"Chen, R. et al. A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasis. J. Hepatol. 79, 1478\u20131490 (2023).","journal-title":"J. Hepatol."},{"key":"9847_CR5","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jhep.2018.08.020","volume":"69","author":"PM Rodrigues","year":"2018","unstructured":"Rodrigues, P. M. et al. Primary biliary cholangitis: A tale of epigenetically-induced secretory failure? J. Hepatol. 69, 1371\u20131383 (2018).","journal-title":"J. Hepatol."},{"key":"9847_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cmet.2024.09.008","volume":"37","author":"L Song","year":"2025","unstructured":"Song, L. et al. Hepatic Fxr-Fgf4 is required for bile acid homeostasis via an FgfR4-LRH-1 signal node under cholestatic stress. Cell Metab. 37, 104\u2013120.e9 (2025).","journal-title":"Cell Metab."},{"key":"9847_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jare.2023.06.009","volume":"59","author":"Z Cheng","year":"2025","unstructured":"Cheng, Z. et al. Bile acid and nonalcoholic steatohepatitis: Molecular insights and therapeutic targets. J. Adv. Res. 59, 173\u2013187 (2024).","journal-title":"J. Adv. Res"},{"key":"9847_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12929","volume":"76","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Melatonin improves cholestatic liver disease via the gut-liver axis. J. Pineal Res. 76, e12929 (2024).","journal-title":"J. Pineal Res."},{"key":"9847_CR9","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1136\/gutjnl-2017-314553","volume":"67","author":"CD Fuchs","year":"2018","unstructured":"Fuchs, C. D. et al. Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2-\/- mice by modulating composition, signalling and excretion of faecal bile acids. Gut 67, 1683\u20131691 (2018).","journal-title":"Gut"},{"key":"9847_CR10","doi-asserted-by":"publisher","first-page":"6082","DOI":"10.1021\/acs.jmedchem.2c01918","volume":"66","author":"Q Ren","year":"2023","unstructured":"Ren, Q. et al. Discovery of thE First-in-class Intestinal Restricted Fxr and FABP1 dual modulator ZLY28 for the treatment of nonalcoholic fatty liver disease. J. Med. Chem. 66, 6082\u20136104 (2023).","journal-title":"J. Med. Chem."},{"key":"9847_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41564-023-01570-0","volume":"9","author":"C Liu","year":"2024","unstructured":"Liu, C. et al. Gut commensal Christensenella minuta modulates host metabolism via acylated secondary bile acids. Nat. Microbiol. 9, 434\u2013450 (2024).","journal-title":"Nat. Microbiol."},{"key":"9847_CR12","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/hep.30975","volume":"71","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Probiotic Lactobacillus rhamnosus GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice. Hepatol. Balt. Md 71, 2050\u20132066 (2020).","journal-title":"Hepatol. Balt. Md"},{"key":"9847_CR13","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2390176","volume":"16","author":"L Wu","year":"2024","unstructured":"Wu, L. et al. Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion. Gut Microbes 16, 2390176 (2024).","journal-title":"Gut Microbes"},{"key":"9847_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade4395","volume":"9","author":"Y Zhou","year":"2023","unstructured":"Zhou, Y. et al. Structural insights into the assembly of gp130 family cytokine signaling complexes. Sci. Adv. 9, eade4395 (2023).","journal-title":"Sci. Adv."},{"key":"9847_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1142586","volume":"11","author":"P Boyd","year":"2023","unstructured":"Boyd, P., Campbell, L. J. & Hyde, D. R. CLCF1\/Crlf1a-mediated signaling is neuroprotective and required for M\u00fcller glia proliferation in the light-damaged zebrafish retina. Front. Cell Dev. Biol. 11, 1142586 (2023).","journal-title":"Front. Cell Dev. Biol."},{"key":"9847_CR16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2310711121","volume":"121","author":"Y Yuan","year":"2024","unstructured":"Yuan, Y. et al. CLCF1 inhibits energy expenditure via suppressing brown fat thermogenesis. Proc. Natl. Acad. Sci. USA 121, e2310711121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9847_CR17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2305717120","volume":"120","author":"M Ding","year":"2023","unstructured":"Ding, M. et al. CLCF1 signaling restrains thermogenesis and disrupts metabolic homeostasis by inhibiting mitochondrial biogenesis in brown adipocytes. Proc. Natl. Acad. Sci. USA 120, e2305717120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9847_CR18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cytogfr.2015.07.014","volume":"26","author":"NA Sims","year":"2015","unstructured":"Sims, N. A. Cardiotrophin-like cytokine factor 1 (CLCF1) and neuropoietin (NP) signalling and their roles in development, adulthood, cancer and degenerative disorders. Cytokine Growth Factor Rev. 26, 517\u2013522 (2015).","journal-title":"Cytokine Growth Factor Rev."},{"key":"9847_CR19","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/hep.32719","volume":"78","author":"T Liu","year":"2023","unstructured":"Liu, T. et al. Intrahepatic paracrine signaling by cardiotrophin-like cytokine factor 1 ameliorates diet-induced NASH in mice. Hepatology 78, 1478\u20131491 (2023).","journal-title":"Hepatology"},{"key":"9847_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s10020-022-00589-z","volume":"28","author":"J Pan","year":"2022","unstructured":"Pan, J. et al. Hypolipidemic effect of ethanol extract from Chimonanthus nitens Oliv. leaves in hyperlipidemia rats via activation of the leptin\/JAK2\/STAT3 pathway. Mol. Med. 28, 159 (2022).","journal-title":"Mol. Med."},{"key":"9847_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1136\/gut.2008.151175","volume":"59","author":"X Jin","year":"2010","unstructured":"Jin, X., Zimmers, T. A., Zhang, Z., Pierce, R. H. & Koniaris, L. G. Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice. Gut 59, 186\u2013196 (2010).","journal-title":"Gut"},{"key":"9847_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32080-3","volume":"8","author":"A Gotoh","year":"2018","unstructured":"Gotoh, A. et al. Sharing of human milk oligosaccharides degradants within bifidobacterial communities in faecal cultures supplemented with Bifidobacterium bifidum. Sci. Rep. 8, 13958 (2018).","journal-title":"Sci. Rep."},{"key":"9847_CR23","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.14309\/ajg.0000000000000557","volume":"115","author":"CF Murillo Perez","year":"2020","unstructured":"Murillo Perez, C. F. et al. Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase. Am. J. Gastroenterol. 115, 1066\u20131074 (2020).","journal-title":"Am. J. Gastroenterol."},{"key":"9847_CR24","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/hep.30348","volume":"69","author":"E Santamar\u00eda","year":"2019","unstructured":"Santamar\u00eda, E. et al. The Epidermal growth factor receptor ligand Amphiregulin protects from cholestatic liver injury and regulates bile acids synthesis. Hepatology 69, 1632\u20131647 (2019).","journal-title":"Hepatology"},{"key":"9847_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59959-w","volume":"16","author":"JS Kang","year":"2025","unstructured":"Kang, J. S. et al. Exercise-induced CLCF1 attenuates age-related muscle and bone decline in mice. Nat. Commun. 16, 4743 (2025).","journal-title":"Nat. Commun."},{"key":"9847_CR26","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/j.jacc.2022.03.370","volume":"79","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y. et al. Disruption of Circadian rhythms by shift work exacerbates reperfusion injury in myocardial infarction. J. Am. Coll. Cardiol. 79, 2097\u20132115 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"9847_CR27","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1097\/HEP.0000000000001438","volume":"82","author":"M Trauner","year":"2025","unstructured":"Trauner, M., Karpen, S. J. & Dawson, P. A. Benefits and challenges to therapeutic targeting of bile acid circulation in cholestatic liver disease. Hepatol. Balt. Md 82, 855\u2013876 (2025).","journal-title":"Hepatol. Balt. Md"},{"key":"9847_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12016-025-09074-x","volume":"68","author":"X Men","year":"2025","unstructured":"Men, X. et al. The treatment of primary biliary cholangitis: time for personalized medicine. Clin. Rev. Allergy Immunol. 68, 63 (2025).","journal-title":"Clin. Rev. Allergy Immunol"},{"key":"9847_CR29","first-page":"1068","volume":"50","author":"M Zhang","year":"2018","unstructured":"Zhang, M. et al. FXR deletion in hepatocytes does not affect the severity of alcoholic liver disease in mice. Dig. Liver Dis. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver 50, 1068\u20131075 (2018).","journal-title":"Dig. Liver Dis. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"key":"9847_CR30","first-page":"570","volume":"51","author":"B Kong","year":"2019","unstructured":"Kong, B. et al. Fxr deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury. Dig. Liver Dis. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver 51, 570\u2013576 (2019).","journal-title":"Dig. Liver Dis. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"key":"9847_CR31","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","volume":"130","author":"A Par\u00e9s","year":"2006","unstructured":"Par\u00e9s, A., Caballer\u00eda, L. & Rod\u00e9s, J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. Gastroenterology 130, 715\u2013720 (2006).","journal-title":"Gastroenterology"},{"key":"9847_CR32","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1074\/jbc.274.1.305","volume":"274","author":"C Postic","year":"1999","unstructured":"Postic, C. et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274, 305\u2013315 (1999).","journal-title":"J. Biol. Chem."},{"key":"9847_CR33","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583 (2016).","journal-title":"Nat. Methods"},{"key":"9847_CR34","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852\u2013857 (2019).","journal-title":"Nat. Biotechnol."},{"key":"9847_CR35","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1093\/bioinformatics\/bti430","volume":"21","author":"X Mao","year":"2005","unstructured":"Mao, X., Cai, T., Olyarchuk, J. G. & Wei, L. Automated genome annotation and pathway identification using the KEGG Orthology (KO) as a controlled vocabulary. Bioinforma. Oxf. Engl. 21, 3787\u20133793 (2005).","journal-title":"Bioinforma. Oxf. Engl."},{"key":"9847_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155610","volume":"145","author":"Y Xia","year":"2023","unstructured":"Xia, Y. et al. Glutaredoxin 1 regulates cholesterol metabolism and gallstone formation by influencing protein S-glutathionylation. Metabolism 145, 155610 (2023).","journal-title":"Metabolism"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09847-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09847-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09847-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:06:03Z","timestamp":1773698763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09847-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9847"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09847-w","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"370"}}